(Q74145280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

chronic progressive multiple sclerosis

1 reference

L La Mantia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Eoli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Salmaggi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

V Torri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Milanese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

Italian journal of neurological sciences

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

32-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials

9 November 2019

cites work

1 reference

12 December 2020

Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis

1 reference

12 December 2020

[Multiple sclerosis and the autoimmunization process. Treatment by antimitotics]

1 reference

12 December 2020

Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis

1 reference

12 December 2020

Diagnosis and classification of multiple sclerosis

1 reference

12 December 2020

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

1 reference

12 December 2020

Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients

1 reference

12 December 2020

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Immunodepressive therapy in neurology

1 reference

12 December 2020

Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone

1 reference

12 December 2020

Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis

1 reference

12 December 2020

[Cyclophosphamide bolus therapy in lupus nephritis]

1 reference

12 December 2020

Cyclophosphamide toxicity. Characterising and avoiding the problem

1 reference

12 December 2020

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

12 December 2020

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group

1 reference

12 December 2020

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

1 reference

12 December 2020

Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapy

1 reference

12 December 2020

Cyclophosphamide and MS

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03028809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10935857%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference